Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 8
2008 26
2009 17
2010 23
2011 35
2012 29
2013 30
2014 33
2015 36
2016 45
2017 35
2018 34
2019 29
2020 15
Text availability
Article attribute
Article type
Publication date

Search Results

340 results
Results by year
Filters applied: . Clear all
Page 1
Targeting the IL-6/JAK/STAT3 signalling axis in cancer.
Johnson DE, O'Keefe RA, Grandis JR. Johnson DE, et al. Nat Rev Clin Oncol. 2018 Apr;15(4):234-248. doi: 10.1038/nrclinonc.2018.8. Epub 2018 Feb 6. Nat Rev Clin Oncol. 2018. PMID: 29405201 Free PMC article. Review.
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.
Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington K, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Iglesias Docampo LC, Haddad R, Rordorf T, Kiyota N, Tahara M, Monga M, Lynch M, Geese WJ, Kopit J, Shaw JW, Gillison ML. Ferris RL, et al. N Engl J Med. 2016 Nov 10;375(19):1856-1867. doi: 10.1056/NEJMoa1602252. Epub 2016 Oct 8. N Engl J Med. 2016. PMID: 27718784 Free PMC article. Clinical Trial.
Comprehensive genomic characterization of head and neck squamous cell carcinomas.
Cancer Genome Atlas Network. Cancer Genome Atlas Network. Nature. 2015 Jan 29;517(7536):576-82. doi: 10.1038/nature14129. Nature. 2015. PMID: 25631445 Free PMC article.
LAG3 (CD223) as a cancer immunotherapy target.
Andrews LP, Marciscano AE, Drake CG, Vignali DA. Andrews LP, et al. Immunol Rev. 2017 Mar;276(1):80-96. doi: 10.1111/imr.12519. Immunol Rev. 2017. PMID: 28258692 Free PMC article. Review.
EGFR-targeted therapies in the post-genomic era.
Xu MJ, Johnson DE, Grandis JR. Xu MJ, et al. Cancer Metastasis Rev. 2017 Sep;36(3):463-473. doi: 10.1007/s10555-017-9687-8. Cancer Metastasis Rev. 2017. PMID: 28866730 Free PMC article. Review.
Immunotherapy for head and neck cancer: Recent advances and future directions.
Cramer JD, Burtness B, Ferris RL. Cramer JD, et al. Oral Oncol. 2019 Dec;99:104460. doi: 10.1016/j.oraloncology.2019.104460. Epub 2019 Nov 1. Oral Oncol. 2019. PMID: 31683169 Review.
Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.
Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, Harrington KJ, Kasper S, Vokes EE, Even C, Worden F, Saba NF, Docampo LCI, Haddad R, Rordorf T, Kiyota N, Tahara M, Lynch M, Jayaprakash V, Li L, Gillison ML. Ferris RL, et al. Oral Oncol. 2018 Jun;81:45-51. doi: 10.1016/j.oraloncology.2018.04.008. Epub 2018 Apr 17. Oral Oncol. 2018. PMID: 29884413 Free PMC article. Clinical Trial.
Immunology and Immunotherapy of Head and Neck Cancer.
Ferris RL. Ferris RL. J Clin Oncol. 2015 Oct 10;33(29):3293-304. doi: 10.1200/JCO.2015.61.1509. Epub 2015 Sep 8. J Clin Oncol. 2015. PMID: 26351330 Free PMC article. Review.
Isothiocyanates: Translating the Power of Plants to People.
Palliyaguru DL, Yuan JM, Kensler TW, Fahey JW. Palliyaguru DL, et al. Mol Nutr Food Res. 2018 Sep;62(18):e1700965. doi: 10.1002/mnfr.201700965. Epub 2018 Mar 26. Mol Nutr Food Res. 2018. PMID: 29468815 Free PMC article. Review.
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptor.
Ruffo E, Wu RC, Bruno TC, Workman CJ, Vignali DAA. Ruffo E, et al. Semin Immunol. 2019 Apr;42:101305. doi: 10.1016/j.smim.2019.101305. Semin Immunol. 2019. PMID: 31604537 Free PMC article. Review.
340 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page